For citations:

Brose M.S., Worden F.P., Newbold K.L., Guo M., Hurria A. Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial. Head and Neck Tumors (HNT). 2018;8(2):39-52. (In Russ.) https://doi.org/10.17650/2222-1468-2018-8-2-39-52